Hass Corp
Hass Corp operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.
Business. Hass Corp (450330.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in South Korea and is primarily listed on the KOSDAQ exchange. Due to the absence of specific segment or geographic data, the company is described at the industry level as a provider of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Hass Corp (450330.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in South Korea and is primarily listed on the KOSDAQ exchange. Due to the absence of specific segment or geographic data, the company is described at the industry level as a provider of medical equipment and supplies.
Hass Corp maintains a capital structure with a debt-to-equity ratio of 0.75, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.89, suggesting that its current liabilities exceed its current assets. This is further supported by the negative net cash position after subtracting total debt, which signals potential liquidity constraints.
In terms of profitability, Hass Corp reports a return on equity (ROE) of 4.08% and a return on assets (ROA) of 2.19%. These figures are below the industry median for ROE and ROA, indicating that the company is underperforming relative to its peers in terms of generating returns from equity and total assets.
The company's revenue is primarily concentrated in a single geographic region, with no disclosed segment breakdown. This lack of diversification increases the risk of revenue volatility due to regional economic or regulatory changes. The absence of segment data also limits the ability to assess the performance of different product lines or markets.
Hass Corp's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The company's operating cash flow of 393.9 million KRW and free cash flow of 583.9 million KRW suggest some capacity for reinvestment or debt reduction, but the capital expenditure of -325.98 million KRW indicates a net outflow from investment activities. The outlook for the next fiscal year remains uncertain without additional guidance.
The risk assessment for Hass Corp highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could constrain its ability to meet short-term obligations. However, the low dilution risk suggests that the company is not currently issuing shares at a rate that would significantly dilute existing shareholders.
Recent events and filings do not indicate any major corporate actions or strategic shifts. The company's financial statements and disclosures have not revealed any significant legal, regulatory, or operational risks that would materially affect its operations or financial position.
- Hass Corp has a moderate debt-to-equity ratio of 0.75, indicating a balanced capital structure.
- The company's ROE of 4.08% and ROA of 2.19% are below industry medians, suggesting underperformance in profitability.
- Hass Corp's liquidity position is weak, with a current ratio of 0.89 and a negative net cash position after debt.
- The company's growth trajectory is modest, with no significant revenue growth reported in the latest period.
- Hass Corp faces a medium liquidity risk and a low dilution risk, with no major recent events affecting its operations.
Bull / Bear case
Generated · model-assistedOperating and net margins significantly exceed the 75th percentile of the medical equipment cohort, indicating superior profitability.
Free cash flow turned positive in FY0, marking a 199.3% year-over-year improvement from the previous negative position.
Return on equity of 4.08% outperforms the cohort median of 1.42%, demonstrating better capital efficiency than peers.
Revenue grew at a 7.1% compound annual growth rate over the last four years, showing consistent top-line expansion.
The company faces high credit risk, posing a substantial threat to financial stability and potential default.
Debt-to-equity ratio of 0.75 is in the bottom quartile of the cohort, indicating higher financial leverage than peers.
Cash conversion of 0.61 is below the cohort median of 0.84, suggesting weaker efficiency in generating cash from earnings.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Hass Corp Market data — financials · 2026-05-26